Zurich Cantonal Bank
BHVN

Zurich Cantonal Bank’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Zurich Cantonal Bank’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-7,673
Closed -$1.16M – 2976
2022
Q3 		$1.16M Buy
7,673
+352
+5% +$52.2K 0.01% 809
2022
Q2 		$1.07M Sell
7,321
-584
-7% -$74.6K 0.01% 840
2022
Q1 		$937K Sell
7,905
-1,070
-12% -$133K ﹤0.01% 971
2021
Q4 		$1.24M Buy
8,975
+3,562
+66% +$453K 0.01% 913
2021
Q3 		$752K Hold
5,413
– – ﹤0.01% 1047
2021
Q2 		$525K Sell
5,413
-361
-6% -$29.3K ﹤0.01% 1207
2021
Q1 		$395K Sell
5,774
-1,008
-15% -$81.5K ﹤0.01% 1374
2020
Q4 		$581K Buy
6,782
+1,385
+26% +$117K ﹤0.01% 1200
2020
Q3 		$351K Hold
5,397
– – ﹤0.01% 1257
2020
Q2 		$395K Buy
5,397
+1,992
+59% +$106K ﹤0.01% 1128
2020
Q1 		$116K Hold
3,405
– – ﹤0.01% 1526
2019
Q4 		$185K Buy
3,405
+787
+30% +$39K ﹤0.01% 1385
2019
Q3 		$109K Buy
2,618
+362
+16% +$15.3K ﹤0.01% 1576
2019
Q2 		$99K Buy
2,256
+1,097
+95% +$61.8K ﹤0.01% 1634
2019
Q1 		$60K Sell
1,159
-449
-28% -$19.4K ﹤0.01% 1897
2018
Q4 		$59K Hold
1,608
– – ﹤0.01% 1940
2018
Q3 		$60K Buy
1,608
+617
+62% +$22.7K ﹤0.01% 2051
2018
Q2 		$39K Sell
991
-468
-32% -$14.8K ﹤0.01% 2266
2018
Q1 		$38K Hold
1,459
– – ﹤0.01% 2222
2017
Q4 		$39K Buy
+1,459
New +$40.2K ﹤0.01% 2194

Other funds holding BHVN

LIP
Liontrust Investment Partners London, United Kingdom $5.86B AUM 23.75% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
FIA
FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MSCM
McElhenny Sheffield Capital Management Dallas, Texas $404M AUM 19.8% 1-Year Est. Return

Zurich Cantonal Bank's BHVN Position: Q4 2022 in Review

Zurich Cantonal Bank sold out of Biohaven Pharmaceutical Holding Company Ltd. (BHVN) in Q4 2022, closing a stake of 7,673 shares — an estimated $1.16M sold.

Zurich Cantonal Bank first reported a position in BHVN in Q4 2017 and held it in 20 quarters. The position peaked at $1.24M in Q4 2021. 7 funds tracked by Wall St. Rank hold BHVN as of Q4 2022.

  • Zurich Cantonal Bank reported no remaining Biohaven Pharmaceutical Holding Company Ltd. position as of Q4 2022 after selling out during the quarter.
  • Zurich Cantonal Bank sold 7,673 Biohaven Pharmaceutical Holding Company Ltd. shares in Q4 2022, an estimated $1.16M.
  • Zurich Cantonal Bank first reported a position in Biohaven Pharmaceutical Holding Company Ltd. in Q4 2017 and held it in 20 quarters.
  • Zurich Cantonal Bank's Biohaven Pharmaceutical Holding Company Ltd. position peaked at $1.24M in Q4 2021.
  • 7 funds tracked by Wall St. Rank held Biohaven Pharmaceutical Holding Company Ltd. as of Q4 2022.

Based on Zurich Cantonal Bank's 13F filing for Q4 2022, filed 1 Feb 2023.